Back in February, UnitedHealth (UNH) CEO Andrew Witty told top executives that business was good and many were happy with how smoothly the new Medicare coverage rollout was going, Anna Wilde Mathews and Christopher Weaver of The Wall Street Journal reports. Two months later, however, Medicare patients would be at the center of a financial meltdown, with the company announcing disappointing profits and withdrawing its FY25 guidance. The company’s aggressive business practices, regulatory changes, and higher costs for Medicare patients contributed to its financial decline. Witty, lacking experience in the U.S. insurance experience, was subsequentially replaced by the company’s chairman Stephen Hemsley.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- UnitedHealth price target lowered to $400 from $450 at KeyBanc
- Winners and Losers: Energy Stocks Soared and Healthcare Crashed in May
- ‘Buy Now or Regret Later,’ Says Top Investor About UnitedHealth Stock
- Why Buying the UnitedHealth (UNH) Stock Dip is a Bad Idea
- Options Market Offers Compelling Trading Strategy for UnitedHealth Stock (UNH)
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue